GlobalData on MSN1d
EMA establish advisory portal for high-risk medical devices
The EMA anticipates that the ability to access scientific advice will foster innovation among medical device manufacturers.
Moleculin Announces First European Approval for Phase 3 AML Trial
HOUSTON - Moleculin Biotech, Inc. (NASDAQ:MBRX), a late-stage pharmaceutical company currently trading near its 52-week low of $0.66, announced it has received the first European regulatory approval ...
Moleculin Biotech receives first approval in Europe for AML trial recruiting
Moleculin Biotech (MBRX) has received first country regulatory approval in Europe to begin recruiting for its Phase 3 pivotal trial protocol ...
Q4 2024 Aptargroup Inc Earnings Call
Vanessa Kanu Kanu; Executive Vice President and Chief Financial Officer; Aptargroup Inc Ladies and gentlemen, thank you for standing by. Welcome to Aptar 2024 fourth quarter and annual results ...
Physiotherapy Equipment Market Size to Hit USD 38.2 Billion by 2032, at a CAGR of 6.9% - SNS Insider
Global Physiotherapy Equipment Market Growth is fueled by increasing musculoskeletal disorders, technological advancements, and government healthcare investments.Austin, United States, Feb. 07, 2025 ...